Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase ...
In a compelling example of how advanced neurological care can transform lives, a 63-year-old patient from Kakinada, Mr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results